United Therapeutics (UTHR) Receives CRL from FDA for Oral Treprostinil
Go back to United Therapeutics (UTHR) Receives CRL from FDA for Oral Treprostinil| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 521.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $521.00 | 52 Week High | $164.04 | |||
| Open | $521.00 | 52 Week Low | $97.52 | |||
| Day High | $521.00 | P/E | 95.25 | |||
| Day Low | $521.00 | EPS | $5.47 | |||
| Volume | 20 | |||||
